Raj HC: Convicted Minor Gang Rapist Not Fully Barred From Open-Air Camps; Rules Allow Exceptions  ||  Calcutta High Court: Serving a Show-Cause Notice Via Email is Valid under PMLA Regulations  ||  Del HC: Candidate’s Independent Medical Opinions Don’t Justify Fresh Medical Exam in SSC Recruitment  ||  Calcutta HC: Magistrate Must Assess Grounds, Cannot Order Police Inquiry under Section 175(3) BNSS  ||  SC Grants Law Officer Exam Relief, Saying Students Can’t be Blamed When Judges Differ in Views  ||  SC: Fraudulent Diversion of Company Funds Cannot be Validated by Later Shareholder Ratification  ||  SC: Doctor’s View on a Victim’s Consciousness Prevails over Police Assessment in Dying Declarations  ||  SC: Examining Contradictions and Witness Credibility Exceeds the Scope of Section 319 CrPC  ||  Supreme Court Struck Down Section 60(4), Removing Limits on Maternity Benefits For Adoptive Mothers  ||  Supreme Court: Air Force Group Insurance Society qualifies as ‘State’ under Article 12    

Search Results for Tag : Trastuzumab

News

Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Judgments

Delhi High Court to delve into Drug Controller irregularities(25.04.2016)

The Delhi High Court deferred a dispute regarding the development, classification and promotion of bio-similar drugs to 2 June 2016. Brought by Roche .....

Tags : trastuzumab, bio-similar, dcgi, roche



Disclaimer | Copyright 2026 - All Rights Reserved